- Home
- KZIA vs MMLP Comparison
KZIA vs MMLP Comparison
Compare KZIA & MMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KZIA | MMLP |
|---|---|---|
| Founded | 1994 | 2002 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.8M | 90.8M |
| IPO Year | 2002 | 2002 |
Fundamental Metrics
Financial Performance| Metric | KZIA | MMLP |
|---|---|---|
| Price | $14.63 | $2.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $19.50 | $3.00 |
| AVG Volume (30 Days) | ★ 188.8K | 46.7K |
| Earning Date | 06-04-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,653,009,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $4.86 | $1.89 |
| 52 Week High | $17.40 | $3.54 |
Technical Indicators
Market Signals| Indicator | KZIA | MMLP |
|---|---|---|
| Relative Strength Index (RSI) | 64.05 | 41.60 |
| Support Level | $5.62 | N/A |
| Resistance Level | $17.40 | $2.83 |
| Average True Range (ATR) | 1.06 | 0.23 |
| MACD | 0.23 | -0.05 |
| Stochastic Oscillator | 89.70 | 36.94 |
Price Performance
Historical ComparisonAbout KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
About MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused on the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products, including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing, and distribution; and natural gas liquids marketing, distribution and transportation services. The company operates in four segment Terminalling and storage, Transportation, Sulfur service, and Specialty products segment. The majority of the revenue is derived from the Specialty products segment.